Says care activity increases at twice the rate of 2024. Says “decidedly unsatisfied” with Q1 results. Says Optum Rx off to “strong selling season” in 2025. Comments taken from Q1 earnings conference call.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UNH Earnings: UnitedHealth Stock Crashes on Revised Outlook
- Morgan Stanley expects UnitedHealth shares to fall following guidance cut
- Options Volatility and Implied Earnings Moves Today, April 17, 2025
- UnitedHealth cuts FY25 adjusted EPS view to $26.00-$26.50 from $29.50-$30.00
- UnitedHealth reports Q1 adjusted EPS $7.20, consensus $7.29